We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Sues Apotex to Protect Its Enlarged Prostate Drug Avodart
GSK Sues Apotex to Protect Its Enlarged Prostate Drug Avodart
September 11, 2012
GlaxoSmithKline (GSK) is suing Apotex, saying the generic maker’s proposed version of enlarged prostate drug Avodart would infringe on a GSK patent and should be prohibited from the U.S. market until the patent expires in late 2015.